Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals. Both studies are published in the August 1 issue of The Journal of Infectious Diseases, now available online. William J. Moss, MD, and colleagues at the Johns Hopkins University and elsewhere studied immune responses to measles vaccine in HIV-infected and uninfected children in Zambia from 2000 to 2004, when measles endemic in a country that still has one of the highest HIV prevalence rates in the world. Measles poses a greater fatality risk in HIV-infected children than in uninfected children.
